{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T01:19:01Z","timestamp":1775611141684,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005703","name":"Akdeniz \u00dcniversitesi","doi-asserted-by":"publisher","award":["TTU-2017-2551"],"award-info":[{"award-number":["TTU-2017-2551"]}],"id":[{"id":"10.13039\/501100005703","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-020-00385-2","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T22:02:37Z","timestamp":1611093757000},"page":"85-99","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Alleviation of prilocaine-induced epileptiform activity and cardiotoxicity by thymoquinone"],"prefix":"10.1007","volume":"29","author":[{"given":"Bar\u0131\u015f","family":"Akg\u00fcl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130lker \u00d6ng\u00fc\u00e7","family":"Aycan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enis","family":"Hidi\u015fo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebru","family":"Af\u015far","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sendeg\u00fcl","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamze","family":"Tanr\u0131\u00f6ver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nesil","family":"Co\u015fkunf\u0131rat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suat","family":"Sanl\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0660-971X","authenticated-orcid":false,"given":"Mutay","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"key":"385_CR1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cden.2010.06.015","volume":"54","author":"PA Moore","year":"2010","unstructured":"Moore PA, Hersh EV. Local anesthetics: pharmacology and toxicity. Dent Clin N Am. 2010;54:587\u201399.","journal-title":"Dent Clin N Am."},{"key":"385_CR2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/AAP.0b013e3181d22fcd","volume":"35","author":"JM Neal","year":"2010","unstructured":"Neal JM, Bernards CM, Butterworth JF 4th, Di Gregorio G, Drasner K, Hejtmanek MR, Mulroy MF, Rosenquist RW, Weinberg GL. ASRA practice advisory on local anesthetic systemic toxicity. Reg Anesth Pain Med. 2010;35:152\u201361.","journal-title":"Reg Anesth Pain Med."},{"key":"385_CR3","first-page":"124","volume":"43","author":"M Gitman","year":"2018","unstructured":"Gitman M, Barrington MJ. Local anesthetic systemic toxicity: a review of recent case reports and registries. Reg Anesth Pain Med. 2018;43:124\u201330.","journal-title":"Reg Anesth Pain Med."},{"key":"385_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4103\/1735-3327.95224","volume":"9","author":"P Singh","year":"2012","unstructured":"Singh P. An emphasis on the wide usage and important role of local anesthesia in dentistry: a strategic review. Dent Res J (Isfahan). 2012;9:127\u201332.","journal-title":"Dent Res J (Isfahan)"},{"key":"385_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/LRA.S112756","volume":"10","author":"A Manassero","year":"2017","unstructured":"Manassero A, Fanelli A. Prilocaine hydrochloride 2% hyperbaric solution for intrathecal injection: a clinical review. Local Reg Anesth. 2017;10:15\u201324.","journal-title":"Local Reg Anesth."},{"key":"385_CR6","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1097\/00000542-200211000-00034","volume":"97","author":"Y Auroy","year":"2002","unstructured":"Auroy Y, Benhamou D, Bargues L, Ecoffey C, Falissard B, Mercier FJ, Bouaziz H, Samii K. Major complications of regional anesthesia in France: the SOS regional anesthesia hotline service. Anesthesiology. 2002;97:1274\u201380.","journal-title":"Anesthesiology."},{"key":"385_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.accpm.2016.03.005","volume":"35","author":"J Boublik","year":"2016","unstructured":"Boublik J, Gupta R, Bhar S, Atchabahian A. Prilocaine spinal anesthesia for ambulatory surgery: a review of the available studies. Anaesth Crit Care Pain Med. 2016;35:417\u201321.","journal-title":"Anaesth Crit Care Pain Med."},{"key":"385_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.abd.2019.09.025","volume":"95","author":"ACFP Cherobin","year":"2020","unstructured":"Cherobin ACFP, Tavares GT. Safety of local anesthetics. An Bras Dermatol. 2020;95:82\u201390.","journal-title":"An Bras Dermatol."},{"key":"385_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1134\/S0006297920020042","volume":"85","author":"NK Isaev","year":"2020","unstructured":"Isaev NK, Chetverikov NS, Stelmashook EV, Genrikhs EE, Khaspekov LG, Illarioshkin SN. Thymoquinone as a potential Neuroprotector in acute and chronic forms of cerebral pathology. Biochemistry (Mosc). 2020;85:167\u201376.","journal-title":"Biochemistry (Mosc)"},{"key":"385_CR10","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.apjtm.2017.08.020","volume":"10","author":"T Farkhondeh","year":"2017","unstructured":"Farkhondeh T, Samarghandian S, Borji A. An overview on cardioprotective and anti-diabetic effects of thymoquinone. Asian Pac J Trop Med. 2017;10:849\u201354.","journal-title":"Asian Pac J Trop Med."},{"key":"385_CR11","doi-asserted-by":"publisher","first-page":"1209801","DOI":"10.1155\/2018\/1209801","volume":"2018","author":"M Jakaria","year":"2018","unstructured":"Jakaria M, Cho DY, Ezazul Haque M, Karthivashan G, Kim IS, Ganesan P, Choi DK. Neuropharmacological potential and delivery prospects of thymoquinone for neurological disorders. Oxidative Med Cell Longev. 2018;2018:1209801.","journal-title":"Oxidative Med Cell Longev."},{"key":"385_CR12","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/glia.22317","volume":"60","author":"DK Binder","year":"2012","unstructured":"Binder DK, Nagelhus EA, Ottersen OP. Aquaporin-4 and epilepsy. Glia. 2012;60:1203\u201314.","journal-title":"Glia."},{"key":"385_CR13","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1399-6576.1993.tb03803.x","volume":"37","author":"PH Rosenberg","year":"1993","unstructured":"Rosenberg PH, Zou J, Heavner JE. Comparison of acute central nervous system and cardiovascular toxicity of 2-chloroprocaine and prilocaine in the rat. Acta Anaesthesiol Scand. 1993;37:751\u20135.","journal-title":"Acta Anaesthesiol Scand."},{"key":"385_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.fct.2018.06.038","volume":"118","author":"\u0130\u00d6 Aycan","year":"2018","unstructured":"Aycan \u0130\u00d6, Elpek \u00d6, Akkaya B, K\u0131ra\u00e7 E, Tuzcu H, Kaya S, Co\u015fkunf\u0131rat N, Aslan M. Diclofenac induced gastrointestinal and renal toxicity is alleviated by thymoquinone treatment. Food Chem Toxicol. 2018;118:795\u2013804.","journal-title":"Food Chem Toxicol."},{"key":"385_CR15","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.3390\/molecules19055925","volume":"19","author":"JM Salmani","year":"2014","unstructured":"Salmani JM, Asghar S, Lv H, Zhou J. Aqueous solubility and degradation kinetics of the phytochemical anticancer thymoquinone; probing the effects of solvents, pH and light. Molecules. 2014;19:5925\u201339.","journal-title":"Molecules."},{"key":"385_CR16","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/ejn.13832","volume":"47","author":"E Hidisoglu","year":"2018","unstructured":"Hidisoglu E, Kantar-Gok D, Er H, Acun AD, Yargicoglu P. Alterations in spontaneous delta and gamma activity might provide clues to detect changes induced by amyloid-\u03b2 administration. Eur J Neurosci. 2018;47:1013\u201323.","journal-title":"Eur J Neurosci."},{"key":"385_CR17","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1080\/09553002.2018.1492166","volume":"94","author":"E Hidisoglu","year":"2018","unstructured":"Hidisoglu E, Kantar-Gok D, Ozen S, Yargicoglu P. Short-term 2.1\u2009GHz radiofrequency radiation treatment induces significant changes on the auditory evoked potentials in adult rats. Int J Radiat Biol. 2018;94:858\u201371.","journal-title":"Int J Radiat Biol."},{"issue":"4","key":"385_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/00004647-200204000-00001","volume":"22","author":"J Badaut","year":"2002","unstructured":"Badaut J, Lasbennes F, Magistretti PJ, Regli L. Aquaporins in brain: distribution, physiology, and pathophysiology. J Cereb Blood Flow Metab. 2002;22(4):367\u201378.","journal-title":"J Cereb Blood Flow Metab."},{"key":"385_CR19","doi-asserted-by":"publisher","unstructured":"Gonca E, \u00c7atli D, Erdem S. The effects of thymoquinone on bupivacaine-induced cardiotoxicity. Karaelmas Fen ve M\u00fch Derg. 2019; https:\/\/doi.org\/10.7212\/zkufbd.v9i1.1246.","DOI":"10.7212\/zkufbd.v9i1.1246"},{"key":"385_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2165\/00002018-199818040-00001","volume":"18","author":"M Naguib","year":"1998","unstructured":"Naguib M, Magboul MM, Samarkandi AH, Attia M. Adverse effects and drug interactions associated with local and regional anaesthesia. Drug Saf. 1998;18:221\u201350.","journal-title":"Drug Saf."},{"key":"385_CR21","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1213\/ane.0b013e31816d12af","volume":"106","author":"SE Copeland","year":"2008","unstructured":"Copeland SE, Ladd LA, Gu XQ, Mather LE. The effects of general anesthesia on the central nervous and cardiovascular system toxicity of local anesthetics. Anesth Analg. 2008;106:1429\u201339.","journal-title":"Anesth Analg."},{"key":"385_CR22","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1742-7843.2008.00313.x","volume":"103","author":"U Ebru","year":"2008","unstructured":"Ebru U, Burak U, Yusuf S, Reyhan B, Arif K, Faruk TH, Emin M, Aydin K, Atilla II, Semsettin S, Kemal E. Cardioprotective effects of Nigella sativa oil on cyclosporine A-induced cardiotoxicity in rats. Basic Clin Pharmacol Toxicol. 2008;103:574\u201380.","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"385_CR23","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s13105-013-0272-5","volume":"69","author":"AA Seif","year":"2013","unstructured":"Seif AA. Nigella sativa attenuates myocardial ischemic reperfusion injury in rats. J Physiol Biochem. 2013;69:937\u201344.","journal-title":"J Physiol Biochem."},{"key":"385_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/1735-5362.199050","volume":"12","author":"F Norouzi","year":"2017","unstructured":"Norouzi F, Abareshi A, Asgharzadeh F, Beheshti F, Hosseini M, Farzadnia M, Khazaei M. The effect of Nigella sativa on inflammation-induced myocardial fibrosis in male rats. Res Pharm Sci. 2017;12:74\u201381.","journal-title":"Res Pharm Sci."},{"key":"385_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/1871529X16666160729115249","volume":"16","author":"M Hebi","year":"2016","unstructured":"Hebi M, Zeggwagh N, Hajj L, Bouhali BE, Eddouks M. Cardiovascular effect of Nigella sativa L. aqueous extract in normal rats. Cardiovasc Hematol Disord Drug Targets. 2016;16:47\u201355.","journal-title":"Cardiovasc Hematol Disord Drug Targets."},{"key":"385_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12012-012-9181-z","volume":"13","author":"A Shabana","year":"2013","unstructured":"Shabana A, El-Menyar A, Asim M, Al-Azzeh H, Al TH. Cardiovascular benefits of black cumin (Nigella sativa). Cardiovasc Toxicol. 2013;13:9\u201321.","journal-title":"Cardiovasc Toxicol."},{"key":"385_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/LRA.S154512","volume":"11","author":"K El-Boghdadly","year":"2018","unstructured":"El-Boghdadly K, Pawa A, Chin KJ. Local anesthetic systemic toxicity: current perspectives. Local Reg Anesth. 2018;11:35\u201344.","journal-title":"Local Reg Anesth."},{"key":"385_CR28","first-page":"104","volume":"6","author":"F Beheshti","year":"2016","unstructured":"Beheshti F, Khazaei M, Hosseini M. Neuropharmacological effects of Nigella sativa. Avicenna J Phytomed. 2016;6:104\u201316.","journal-title":"Avicenna J Phytomed."},{"key":"385_CR29","doi-asserted-by":"publisher","first-page":"841823","DOI":"10.1155\/2015\/841823","volume":"2015","author":"MR Khazdair","year":"2015","unstructured":"Khazdair MR. The protective effects of Nigella sativa and its constituents on induced neurotoxicity. J Toxicol. 2015;2015:841823.","journal-title":"J Toxicol."},{"key":"385_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s11064-012-0905-z","volume":"38","author":"NM Arafa","year":"2013","unstructured":"Arafa NM, Abdel-Rahman M, El-khadragy MF, Kassab RB. Evaluation of the possible epileptogenic activity of ciprofloxacin: the role of Nigella sativa on amino acids neurotransmitters. Neurochem Res. 2013;38:174\u201385.","journal-title":"Neurochem Res."},{"key":"385_CR31","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jtcme.2015.06.003","volume":"6","author":"M Seghatoleslam","year":"2015","unstructured":"Seghatoleslam M, Alipour F, Shafieian R, Hassanzadeh Z, Edalatmanesh MA, Sadeghnia HR, Hosseini M. The effects of Nigella sativa on neural damage after pentylenetetrazole induced seizures in rats. J Tradit Complement Med. 2015;6:262\u20138.","journal-title":"J Tradit Complement Med."},{"key":"385_CR32","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.neuropharm.2005.04.004","volume":"49","author":"A Ilhan","year":"2005","unstructured":"Ilhan A, Gurel A, Armutcu F, Kamisli S, Iraz M. Antiepileptogenic and antioxidant effects of Nigella sativa oil against pentylenetetrazol-induced kindling in mice. Neuropharmacology. 2005;49:456\u201364.","journal-title":"Neuropharmacology."},{"key":"385_CR33","first-page":"15","volume":"2","author":"M Raza","year":"2008","unstructured":"Raza M, Alghasham AA, Alorainy MS, El-Hadiyah TM. Potentiation of valproate-induced anticonvulsant response by Nigella sativa seed constituents: the role of GABA receptors. Int J Health Sci (Qassim). 2008;2:15\u201325.","journal-title":"Int J Health Sci (Qassim)."},{"key":"385_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.yebeh.2012.03.026","volume":"24","author":"NA Noor","year":"2012","unstructured":"Noor NA, Aboul Ezz HS, Faraag AR, Khadrawy YA. Evaluation of the antiepileptic effect of curcumin and Nigella sativa oil in the pilocarpine model of epilepsy in comparison with valproate. Epilepsy Behav. 2012;24:199\u2013206.","journal-title":"Epilepsy Behav."},{"key":"385_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.eplepsyres.2010.10.010","volume":"93","author":"J Akhondian","year":"2011","unstructured":"Akhondian J, Kianifar H, Raoofziaee M, Moayedpour A, Toosi MB, Khajedaluee M. The effect of thymoquinone on intractable pediatric seizures (pilot study). Epilepsy Res. 2011;93:39\u201343.","journal-title":"Epilepsy Res."},{"key":"385_CR36","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.bbi.2008.03.009","volume":"22","author":"A Vezzani","year":"2008","unstructured":"Vezzani A, Balosso S, Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun. 2008;22:797\u2013803.","journal-title":"Brain Behav Immun."},{"key":"385_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neuropharm.2012.04.004","volume":"69","author":"A Vezzani","year":"2013","unstructured":"Vezzani A, Friedman A, Dingledine RJ. The role of inflammation in epileptogenesis. Neuropharmacology. 2013;69:16\u201324.","journal-title":"Neuropharmacology."},{"key":"385_CR38","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1016\/j.febslet.2011.08.033","volume":"585","author":"MB Graeber","year":"2011","unstructured":"Graeber MB, Li W, Rodriguez ML. Role of microglia in CNS inflammation. FEBS Lett. 2011;585:3798\u2013805.","journal-title":"FEBS Lett."},{"key":"385_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0079-6123(06)61012-1","volume":"161","author":"Z Zador","year":"2007","unstructured":"Zador Z, Bloch O, Yao X, Manley GT. Aquaporins: role in cerebral edema and brain water balance. Prog Brain Res. 2007;161:185\u201394.","journal-title":"Prog Brain Res."},{"key":"385_CR40","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1242\/jcs.02680","volume":"118","author":"S Saadoun","year":"2005","unstructured":"Saadoun S, Papadopoulos MC, Watanabe H, Yan D, Manley GT, Verkman AS. Involvement of aquaporin-4 in astroglial cell migration and glial scar formation. J Cell Sci. 2005;118:5691\u20138.","journal-title":"J Cell Sci."},{"key":"385_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5698\/1535-7511-14.s2.3","volume":"14","author":"A Vezzani","year":"2014","unstructured":"Vezzani A. Epilepsy and inflammation in the brain: overview and pathophysiology. Epilepsy Curr. 2014;14:3\u20137.","journal-title":"Epilepsy Curr."},{"key":"385_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneuroim.2018.04.018","volume":"320","author":"MK Cobourne-Duval","year":"2018","unstructured":"Cobourne-Duval MK, Taka E, Mendonca P, Soliman KFA. Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NF\u03baB pathway signaling targets in LPS\/IFN\u03b3 -activated BV-2 microglia cells. J Neuroimmunol. 2018;320:87\u201397.","journal-title":"J Neuroimmunol."},{"key":"385_CR43","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11010-017-3064-3","volume":"435","author":"R Velagapudi","year":"2017","unstructured":"Velagapudi R, El-Bakoush A, Lepiarz I, Ogunrinade F, Olajide OA. AMPK and SIRT1 activation contribute to inhibition of neuroinflammation by thymoquinone in BV2 microglia. Mol Cell Biochem. 2017;435:149\u201362.","journal-title":"Mol Cell Biochem."},{"key":"385_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.intimp.2017.04.018","volume":"48","author":"R Velagapudi","year":"2017","unstructured":"Velagapudi R, Kumar A, Bhatia HS, El-Bakoush A, Lepiarz I, Fiebich BL, Olajide OA. Inhibition of neuroinflammation by thymoquinone requires activation of Nrf2\/ARE signalling. Int Immunopharmacol. 2017;48:17\u201329.","journal-title":"Int Immunopharmacol."},{"key":"385_CR45","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1007\/s11064-016-2074-y","volume":"41","author":"Y Shao","year":"2016","unstructured":"Shao Y, Feng Y, Xie Y, Luo Q, Chen L, Li B, Chen Y. Protective effects of thymoquinone against convulsant activity induced by lithium-pilocarpine in a model of status epilepticus. Neurochem Res. 2016;41:3399\u2013406.","journal-title":"Neurochem Res."},{"key":"385_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1515\/tnsci-2017-0003","volume":"8","author":"YY Shao","year":"2017","unstructured":"Shao YY, Li B, Huang YM, Luo Q, Xie YM, Chen YH. Thymoquinone attenuates brain injury via an anti-oxidative pathway in a status epilepticus rat model. Transl Neurosci. 2017;8:9\u201314.","journal-title":"Transl Neurosci."},{"key":"385_CR47","first-page":"1215","volume":"26","author":"MA Randhawa","year":"2013","unstructured":"Randhawa MA, Alghamdi MS, Maulik SK. The effect of thymoquinone, an active component of Nigella sativa, on isoproterenol induced myocardial injury. Pak J Pharm Sci. 2013;26:1215\u20139.","journal-title":"Pak J Pharm Sci."},{"key":"385_CR48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4103\/0253-7613.174585","volume":"48","author":"MS Al-Nimer","year":"2016","unstructured":"Al-Nimer MS, Rajab BR, Al-Aani HA. Thymoquinone protects the heart against isoproterenol-induced myocardial ischemia in mice: a histopathological study. Indian J Pharmacol. 2016;48:97\u20138.","journal-title":"Indian J Pharmacol."},{"key":"385_CR49","doi-asserted-by":"publisher","first-page":"143629","DOI":"10.1155\/2015\/143629","volume":"2015","author":"S Ojha","year":"2015","unstructured":"Ojha S, Azimullah S, Mohanraj R, Sharma C, Yasin J, Arya DS, Adem A. Thymoquinone protects against myocardial ischemic injury by mitigating oxidative stress and inflammation. Evid Based Complement Alternat Med. 2015;2015:143629.","journal-title":"Evid Based Complement Alternat Med."},{"key":"385_CR50","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1159\/000490216","volume":"47","author":"Y Lu","year":"2018","unstructured":"Lu Y, Feng Y, Liu D, Zhang Z, Gao K, Zhang W, Tang H. Thymoquinone attenuates myocardial ischemia\/reperfusion injury through activation of SIRT1 signaling. Cell Physiol Biochem. 2018;47:1193\u2013206.","journal-title":"Cell Physiol Biochem."},{"key":"385_CR51","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.3892\/mmr.2016.4823","volume":"13","author":"H Liu","year":"2016","unstructured":"Liu H, Liu HY, Jiang YN, Li N. Protective effect of thymoquinone improves cardiovascular function, and attenuates oxidative stress, inflammation and apoptosis by mediating the PI3K\/Akt pathway in diabetic rats. Mol Med Rep. 2016;13:2836\u201342.","journal-title":"Mol Med Rep."},{"key":"385_CR52","first-page":"4987","volume":"15","author":"Y Chen","year":"2018","unstructured":"Chen Y, Wang B, Zhao H. Thymoquinone reduces spinal cord injury by inhibiting inflammatory response, oxidative stress and apoptosis via PPAR-\u03b3 and PI3K\/Akt pathways. Exp Ther Med. 2018;15:4987\u201394.","journal-title":"Exp Ther Med."},{"key":"385_CR53","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1124\/dmd.113.051714","volume":"41","author":"R Higuchi","year":"2013","unstructured":"Higuchi R, Fukami T, Nakajima M, Yokoi T. Prilocaine- and lidocaine-induced methemoglobinemia is caused by human carboxylesterase-, CYP2E1-, and CYP3A4-mediated metabolic activation. Drug Metab Dispos. 2013;41:1220\u201330.","journal-title":"Drug Metab Dispos."},{"key":"385_CR54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1399-6576.1968.tb05453.x","volume":"12","author":"J Heinonen","year":"1968","unstructured":"Heinonen J, Ahtee L. Influence of enzyme inducer on methaemoglobinaemia caused by prilocaine. Acta Anaesthesiol Scand. 1968;12:23\u20139.","journal-title":"Acta Anaesthesiol Scand."},{"key":"385_CR55","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/bja\/aes027","volume":"108","author":"A Perks","year":"2012","unstructured":"Perks A, Cheema S, Mohanraj R. Anaesthesia and epilepsy. Br J Anaesth. 2012;108:562\u201371.","journal-title":"Br J Anaesth."},{"key":"385_CR56","doi-asserted-by":"publisher","first-page":"329","DOI":"10.18433\/J30D2V","volume":"20","author":"N Motayagheni","year":"2017","unstructured":"Motayagheni N, Phan S, Nozari A, Atala A. Lipid emulsion, more than reversing bupivacaine Cardiotoxicity: potential organ protection. J Pharm Pharm Sci. 2017;20:329\u201331.","journal-title":"J Pharm Pharm Sci."}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-020-00385-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-020-00385-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-020-00385-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T13:19:12Z","timestamp":1674911952000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-020-00385-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["385"],"URL":"https:\/\/doi.org\/10.1007\/s40199-020-00385-2","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]},"assertion":[{"value":"28 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}